Abstrak
Family planning, as one of the Indonesian Government's program for development, strives to promote welfare by creating small, happy and prosperous families. One of the main efforts in Family Planning is birth arrangement, i.e. having 'ideal' number of children, ideal birth spacing between children and ideal age to give birth. 1, 2 Most of the success of birth arrangement is related to the use of contraception. There are many reasons for choosing one mode of contraception e.g. its effectiveness, its convenience or its minimal side effects. 3, 4, 5 In the last five years there are an increase in the use of hormonal contraception in the District of Kulon Progo, Jogjakarta, Indonesia. 6 Hormonal contraception is known to be related to weight gain. 5, 7 Progesterone in a steroid contraceptive drug influences the metabolism of nutrients, i.e. by promoting anabolism and by increasing appetite. Estrogen leads to the deposition of fat in the subcutaneous tissue and causes increased absorption of salt and water. The weight gain occurs gradually. 8, 9 Obesity is closely related to some diseases such as hypertension, coronary heart diseases, diabetes mellitus and respiratory diseases. Epidemiological studies have shown the increased risk of mortality and morbidity to such diseases in people with obesity. 10 The study is intended to assess the risk of obesity in hormonal contraceptive users in the District of Kulon Progo, Jogjakarta, Indonesia.
METHODS
This is a case control study, using obese contraceptive users as cases and non-obese contraceptive users as controls. A preliminary survey was done to find the prevalence of obesity in contraceptive users in the district and was carried out before the main study.
The study was performed in August -October 2001 in Kulon Progo Jogjakarta. Study population were female contraceptive users living in the district during the study period. Subjects were excluded if they still gave breastfeeding or had chronic diseases such as tuberculosis and malaria.
The study was approved by the ethical committee of Gadjah Mada University, Jogjakarta, Indonesia. Informed consents were obtained from every eligible subject.
Sampling procedures
For a cross sectional survey intended to find the prevalence of obesity in female contraceptive users, 10% of villages were randomly chosen from 88 villages in the district. All female contraceptive users in 9 villages underwent anthropometrics measurements. Interviewers in this study are fieldworkers family planning who had education background in health science. Interview was done in subjects' houses. There were 103 obese subjects, i.e. BMI (body mass index) of more than 25.
Our of those 103 obese subjects, 102 became cases. One obese contraceptive user moved out from the village before the second part of the study. 
Data collection
Data were collected using questionnaire forms and anthropometrics measurements. Training of interviewers and testing of questionnaires were performed before the actual data collection. All interviewers spoke the native languages.
The subject's height was measured with a microtoise to the nearest 0.1 cm, while her weight was measured with a Seca digital scale (Germany) to the nearest 0.1 kg. Due to the tropical weather, light clothing was the custom in the area. Data on weight and height was converted to BMI (body mass index), which is weight (in kg)/square of height (in m). Waist and hip circumferences were measured with non-stretchable tapes to the nearest 0.1 cm. Waist was measured at the level of the navel, while hip was measured at the largest circumference of the hip girdle.
Data on contraceptive utilization included the types of contraception presently used, either hormonal or nonhormonal, and the duration of utilization. The data that respondents might have used hormonal contraceptive sometime in the past was also recorded. Data on her initial body weight before the utilization of the latest contraceptive method was taken from her Family Planning member's card. Other data in the questionnaire were age, parity, level of education, occupation, obesity in either parents and socioeconomic status based on family's income and national standard. This national standard of assessing family welfare divided families into 5 levels of welfare based on ability to purchase food, decent clothing and housing, and health services.
Data on food intake were collected by a 24-hour dietary recall. The dietary recall was performed on three non-consecutive recall days, one of them had to be on Sundays or holidays. Data on energy expenditure were also collected by a 24-hour activity recall. This activity recall was also performed three times, on the same day of the dietary recall.
Data on food intake were analyzed using Food Processor II Nutrition Analysis System 2400 Foods-30 nutrients (Cetapharm/MSD version 3.14, Salem, Oregon, USA), while data on daily energy expenditure were the sum of basal metabolic rate, energy expended for a specific activity per kg body weight per hour -using list by Guthrie, 1986 -and specific dynamic action (Auliana, 1999). Statistical analysis was 95% confidence intervals performed using Epiinfo 2000 version 1.0, 11 and stata.
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RESULTS
Survey in 9 villages in the district found 647 contraceptive users, 103 of whom were obese (15.9%). This preliminary study showed that the village with the highest prevalence of hormonal contraceptive users (62.6%) had the highest prevalence of obesity (27.9%).
The reverse was also true, the less the hormonal contraceptive used, the less was the prevalence of obesity.
The hormonal contraceptives used by our respondents were combination pill (oral pill combination of estrogen and progesterone derivates), intramuscularly injected depot of progesterone derivate and subcutaneous implantation of low-dose levonorgestrel or etonogestrel (implant). The non-hormonal contraceptives used were IUD (intra uterine devices) and tubectomy.
The hormonal contraceptive users had higher risk of being obese compared to the non-hormonal contraceptive users. The risk was highest for users of combination pill, followed by users of injected progesterone depot. Users of implant had no additional risk of obesity compared to the non-hormonal contraceptive users. The risk was still significant after controlling for age, parity, initial body weight, socioeconomic status, education, occupation, daily intake of energy and energy expenditure (see Table 1 , 3 and 5).
There was no difference in the duration of contraceptive utilization between the obese group and the control group, but they had significantly different duration in using hormonal contraception (Table 2) . This difference was still significant after adjusment of other variables in the multivariate model (Table 5 ) was done. A stratified analysis showed that utilization of hormonal contraception for more than seven years related to significantly higher risk of obesity (Table 4) .
Obese parents tend to have obese daughter (Table 1 and 5). Hormonal or non-hormonal contraception did not show any significant effect on energy intake nor energy expenditure (Table 6 ). 
DISCUSSION
Our data shows that users of hormonal contraception, face over all about 9 times risk of obesity compared to users of non-hormonal contraception. The risk is highest when the method of contraception has been used for more than seven years. Kasseru in 1994 reported that injected depot medroxyprogesterone acetat increased weight approximately 2 kg in the first year, while kaushik in 1998 reported a weight gain of 4-6 pounds in the first year. 5, 7, 13, 14 Cushman et al (1996) , also reported that more than 50% of hormonal contraceptive users believed that injected DepoProvera led to weight gain. 15 Our study also showed increased risk of obesity in users of injected progesterone depot, OR: 2.53 (95% CI: 1.1-5.7), but the risk is higher in users of combination pills, OR: 3.17 (95% CI: 1.2-8.5).
Duration in utilization of hormonal contraception is related to higher risk of obesity. Our data showed a steadily increasing risk of obesity the longer the contraception is used. After seven years of using hormonal contraception the risk of obesity is 8.3 folds higher intramuscularly injected depot of progesterone or subcutaneous implantation of low-dose levonorgestrel or etonorgestrel (implant). Longer use of hormonal contraception related to higher risk of obesity. The risk is also higher in offsprings of obese parents.
Recommendations
Offspring of obese parents should be advised to avoi using hormonal contraception, especially combination pills and injected progesterone depot. To avoid obesity, after seven years, continuous utilization of hormonal contraception should be reconsidered.
